Barinthus Biotherapeutics (BRNS) Leases (2020 - 2025)
Historic Leases for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to $2.1 million.
- Barinthus Biotherapeutics' Leases fell 7228.64% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 7228.64%. This contributed to the annual value of $4.4 million for FY2024, which is 4217.12% down from last year.
- Per Barinthus Biotherapeutics' latest filing, its Leases stood at $2.1 million for Q3 2025, which was down 7228.64% from $3.3 million recorded in Q2 2025.
- In the past 5 years, Barinthus Biotherapeutics' Leases ranged from a high of $8.8 million in Q3 2021 and a low of $2.0 million during Q2 2021
- Its 5-year average for Leases is $6.1 million, with a median of $7.4 million in 2024.
- As far as peak fluctuations go, Barinthus Biotherapeutics' Leases soared by 30877.45% in 2022, and later tumbled by 7228.64% in 2025.
- Over the past 5 years, Barinthus Biotherapeutics' Leases (Quarter) stood at $7.3 million in 2021, then increased by 6.83% to $7.8 million in 2022, then dropped by 2.22% to $7.6 million in 2023, then crashed by 42.17% to $4.4 million in 2024, then plummeted by 52.94% to $2.1 million in 2025.
- Its Leases was $2.1 million in Q3 2025, compared to $3.3 million in Q2 2025 and $3.9 million in Q1 2025.